Navigation Links
Torbjorn Bjerke Appointed as new CEO for Karolinska Development
Date:8/23/2010

Torbjorn Bjerke Appointed as new CEO for Karolinska Development -- STOCKHOLM, August 23, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Personnel Announcements Click to view news release full screen  

Torbjorn Bjerke Appointed as new CEO for Karolinska Development

 

STOCKHOLM, August 23, 2010 /PRNewswire/ -- Torbjorn Bjerke has been appointed as new CEO for Karolinska Development. He is currently CEO for Orexo, a position he has held since 2007. Torbjorn Bjerke succeeds Conny Bogentoft who will assume the position as Chief Scientific Officer for Karolinska Development.

Starting its operation in 2003, Karolinska Development has rapidly become one of the leading companies within early pharmaceutical development in Europe. Investments by Karolinska Development have focused on developing its portfolio companies to proof of concept. Karolinska Development has now entered a next phase where the company will seek external partners for some of its portfolio companies while preparing for an initial public offering.

"With his solid background as a commercial leader, Torbjorn Bjerke has the right profile for the role as CEO for Karolinska Development. He has vast experience from leading and developing early research-based companies as well as a listed pharmaceutical company. Torbjorn's experience in business development and his demonstrated ability in negotiating and implementing collaborations with international partners will be of great value to us, our shareholders and our portfolio companies," says Hans Wigzell, Chairman of Karolinska Development.

Torbjorn Bjerke has held the position as CEO for Orexo since 2007. He will assume the position as CEO for Karolinska Development when his successor has been appointed. Conny Bogentoft, who has held the position as CEO for Karolinska Development since its inception in 2003, will become Chief Scientific Officer with overall responsibility for the future development of Karolinska Development's portfolio.

"I look forward to my new role as CEO for Karolinska Development, and to lead one of the most exciting pharmaceutical companies in Europe to further success and a future IPO," says Torbjorn Bjerke.

TO THE EDITORS

About Karolinska Development

Karolinska Development manages one of the largest portfolios of life science companies in Europe. Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation Pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies; among the company's projects 12 compounds are undergoing clinical trials. The portfolio contains a total of 21 potential first-in-class products. http://www.karolinskadevelopment.com

For further information, please contact: Hans Wigzell, Chairman of the board, Karolinska Development Tel: +46(0)705-76-05-39, e-mail: hans.wigzell@ki.se Conny Bogentoft, CEO, Karolinska Development Tel: +46(0)706-88-61-43, e-mail: conny.bogentoft@karolinskadevelopment.com Torbjorn Bjerke, appointed CEO, Karolinska Development Tel: +46(0)708-66-19-90, e-mail: info@karolinskadevelopment.com
'/>"/>

SOURCE Karolinska Development AB PUBL
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shawn Cross Appointed CEO of Burrill Merchant Banking Group
2. New President and CEO appointed at Ocean Nutrition Canada Limited
3. Professor Sander van Deventer Appointed to Supervisory Board of AMT
4. New Board Director Appointed
5. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
6. Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
7. David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
8. Lori Kahler Appointed President of The RC Insight Group
9. Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
10. FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout
11. Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. Stock-Callers.com has initiated coverage on the following equities: ... (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing their ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
Breaking Biology Technology:
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
Breaking Biology News(10 mins):